Incidence and Predictors of Opioid Overdose and Death Among Long-Term Users of Opioid Analgesics
NCT02662153 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 808455
Last updated 2022-07-14
Summary
Retrospective study to assess incidence and predictors of opioid abuse overdose and death associated with opioid overdose among patients prescribed opioid products in long-term use.
Conditions
Interventions
- OTHER
-
Observation only
No intervention.
Sponsors & Collaborators
-
Kaiser Permanente
collaborator OTHER -
HealthCore, Inc.
collaborator INDUSTRY -
Vanderbilt University
collaborator OTHER -
World Health Information Science Consultants, LLC
collaborator OTHER -
Optum, Inc.
collaborator INDUSTRY -
Member Companies of the Opioid PMR Consortium
lead INDUSTRY
Principal Investigators
-
Kenneth R Petronis · Epi Ideas LLC
-
John D Seeger · Optum, Inc.
Eligibility
- Min Age
- 18 Years
- Max Age
- 79 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-05-02
- Primary Completion
- 2021-06-30
- Completion
- 2021-06-30
Countries
- United States
Study Locations
More Related Trials
-
Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users
NCT00158236 ·Status: COMPLETED ·Phase: NA
-
Determining Genetic Biomarkers Predictive of the Development of Prescription Opioid Addiction
NCT01562353 ·Status: UNKNOWN
-
Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder
NCT06086275 ·Status: COMPLETED ·Phase: PHASE1
-
Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse
NCT01967641 ·Status: COMPLETED ·Phase: PHASE2
-
Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool
NCT05706311 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Guiding Aging Long-Term Opioid Therapy Users Into Safer Use Patterns
NCT05808127 ·Status: COMPLETED ·Phase: NA
-
The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy
NCT03337100 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine Microdosing
NCT05307458 ·Status: UNKNOWN
-
A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.
NCT03389750 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine Dose Alteration Study - 1
NCT00000219 ·Status: COMPLETED ·Phase: PHASE1
-
Health Outcomes From Opioid Therapy for Chronic Pain
NCT00495404 ·Status: COMPLETED ·Phase: NA
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
NCT05988710 ·Status: RECRUITING ·Phase: PHASE4
-
Alternate-Day Buprenorphine Administration. Phase VIII - 9
NCT00000227 ·Status: COMPLETED ·Phase: PHASE2
-
Determining the Feasibility of Outpatient Parenteral Antibiotic Therapy for Persons Who Inject Opioids
NCT05300581 ·Status: COMPLETED ·Phase: NA
-
Long-Term Opioid Therapy in Chronic Non-Cancer Pain: Risks and Benefits
NCT06063902 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of a Computerized Opioid Overdose Prevention Program
NCT02040077 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids
NCT00218101 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool
NCT03936985 ·Status: COMPLETED
-
Buprenorphine Pharmacology Related to Addiction Treatment - 18
NCT00000236 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks
NCT02224508 ·Status: COMPLETED
-
Oxycodone User Registry (OUR)
NCT00978328 ·Status: COMPLETED
-
Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use
NCT03266445 ·Status: UNKNOWN ·Phase: PHASE4
-
Overdose Risk Management and Naloxone
NCT03933345 ·Status: UNKNOWN
-
Longitudinal Study of Patients With Opioid-Induced Constipation
NCT01928953 ·Status: COMPLETED
-
Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain
NCT01875848 ·Status: TERMINATED ·Phase: PHASE4